- feeds
- popular
- recent
- reader
- about
- story
- technologies
- what is rss
- connect
- dmca
- contact
- Feed Preview | Life Sciences Legal Update
COVID-19 pandemic: German government further extends foreig... rules with regard to transactions in the life sciences sector
The German Federal Ministry for Economic Affairs and Energy implemented further amendments to the Foreign Trade and Payments Ordinance (Außenwirtschaftsverordnung – AWV) due to the COVID-19 pa...
EU unveils roadmap for EU pharmaceutical strategy
On 2 June, the European Commission (Commission) published a roadmap (Roadmap) that will pave the way for the Commission’s communication on the EU pharmaceutical strategy, which is now due in th...
European Commission Recommendation Could Expedite Access to...onal Protective Equipment Needed to Care for COVID-19 Patients
If they serve health care professionals (HCPs) in EU member states, manufacturers that provide personal protective equipment (PPE) or medical devices used by HCPs caring for known or suspected CO...
German Constitutional Court Rules Germany’s Ratification of the Agreement on a Unified Patent Court is Void
Global life sciences companies have been carefully watching the European effort to launch a Unified Patent Court (UPC). As we discussed in a previous post, the UPC would have a profound effect on...
COVID-19’s Potential Impact on Continuation of Business Relationships in France
As corporations continue to grapple with economic issues surrounding COVID-19, global life sciences companies must start to determine how laws in each of the jurisdictions in which they operate w...
EU funding call for Coronavirus projects
The Innovative Medicines Initiative (IMI) was created in 2008 as a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations ...
Munich Regional Court Clarifies When Claims for Transfers of Patents Become Time-Barred
Germany is one of the most important patent litigation jurisdictions in Europe, making developments in its patent law very important to life sciences companies operating globally. In recent years...
Brexit and the Pharmaceuticals Sector: The Key Issues
The United Kingdom (UK) is scheduled to leave the European Union on 29 March 2019. Certain key aspects of the Brexit deal now seem to have been agreed upon, including a 21 month “transitional p...
Little-Known Trap in U.K. Intellectual Property Litigation ...ccessful Plaintiffs: What Life Sciences Companies Need to Know
Did you know the U.K. patents system penalizes a failure to record a patent transaction at the Patent Office by depriving a successful plaintiff of its entitlement to recover its full legal costs...
Germany – A Major Hub for Patent Litigation
With the Unified Patent Court now stalled for at least the near future, U.S. life sciences companies will continue to face the question of where to bring patent infringement cases in Europe. The ...